Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CARAPACE Study of N-acetylcysteine protection against radiation-induced cellular damage during catheter ablation
2019-001995-12Phase 2Completed
- Sponsor
- Centro Cardiologico Monzino
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of acetylcysteine in arrhythmia (2 arms), sponsored by Centro Cardiologico Monzino. Primary endpoint: Prevention of radiation-induced systemic oxidative stress and genomic DNA oxidative damage. Started Jun 2021; status: completed.
02
Drugs
acetylcysteine
03
Conditions
arrhythmia
Beyond the preview
Go deeper on 2019-001995-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001995-12.